GH Secretagogues

CJC-1295 sem DAC

Also known as: Mod GRF 1-29, CJC-1295 no DAC

Molecular Identifiers

Molecular Formula

C152H252N44O42

CAS Number

863288-34-0

PubChem CID

56841945

Overview

Short-acting version of CJC-1295 (also known as Mod GRF 1-29). Mimics natural GH pulses with a half-life of ~30 minutes. Best results when combined with GHRP peptides such as Ipamorelin or GHRP-2.

Sequence (1 letter): YADAIFTQSYRKVLAQLSARKLLQDILSR
Extended notation: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg

Half-life

~30 minutes

Administration Route

Subcutaneous

Category

GH Secretagogues

Mechanism of Action

  • Modified analog of GHRH (1-29)
  • Pulsatile stimulation of GH secretion
  • Short half-life (~30 min) mimics natural physiology
  • Synergism with GHRP peptides

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter Value
Dose 100-200 mcg per injection
Frequency 2-3 times daily
Timing Morning, post-workout, and before bed
Duration 8-12 weeks

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

  • Facial flushing
  • Headache
  • Dizziness
  • Tingling in extremities

Product Properties

Purity >99%
Appearance White lyophilized powder
Solubility Soluble in bacteriostatic water
Source Solid-phase peptide synthesis (SPPS)
Storage Short-term: <4°C; Long-term: -20°C to -80°C

Presentations & Preparation

Vials of CJC-1295 sem DAC found in the research market:

2 mg5 mg

Reconstitution

  • Diluent: Bacteriostatic water
  • Volume: 2 ml per 2 mg vial
  • Slowly inject the diluent along the vial wall
  • Gently swirl until fully dissolved
  • Never shake

Storage

  • Lyophilized: Room temperature or refrigerated (up to 24 months)
  • Reconstituted: Refrigerated 2-8°C (up to 30 days)
  • Protect from direct light
  • Do not freeze after reconstitution
Reconstitution Calculator

Scientific Studies

Published studies on CJC-1295 sem DAC.

2005 · Endocrinology

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog

Jette L, Leger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bhidon DP

Related Peptides

CJC-1295 with DAC

1-2 mg per week · Once per week

GHRP-2

100-300 mcg per injection · 2-3 times per day

GHRP-6

100-300 mcg per injection · 2-3 times per day

Hexarelin

200-300 mcg per injection · 2-3 times per day

Ipamorelin

200-300 mcg per injection · 2-3 times daily

MK-677

10-25 mg per dose · Once daily